I realize I am being Captain Obvious with this post but

New Post Public Reply Private Reply Replies (1) Message Board
Mo
462
I realize I am being Captain Obvious with this post but whoever the big money entity is that is funding SS is really overpaying for someone who is not very good at their trade. Below you can see that SS is too lazy to change his own alias’s posted FUD and regurgitates it word for word. SS has tried to disrupt this board with multiple aliases but most longs have been blocking their posts and no one is being fooled. Btw, Squatty please spare us the drama about how much you despise your other self.
=======================================
scottsmith
Tuesday, 12/11/18 08:03:52 PM
Re: None
Post # of 251010

Emailed to me by a colleague :

“So what is the consensus on BTD?

Has it been long enough that an answer would have been given?

If it was granted would they have announced it or is it being held under a CDA related to the terms sheet?

If it wasn't granted, why not?

If not, is it because the sample size on the high-dose chemo was too small?

Is anyone worried that we might be told to do a 2B with a larger sample size of high-dose cisplatin?

Is there anyone with the experience to answer these questions?”
===========================
Posted On: 12/11/2018 6:17:39 PM

Posted By: Squar

So what is the consensus on BTD?

Has it been long enough that an answer would have been given?

If it was granted would they have announced it or is it being held under a CDA related to the terms sheet?

If it wasn't granted, why not?

If not, is it because the sample size on the high-dose chemo was too small?

Is anyone worried that we might be told to do a 2B with a larger sample size of high-dose cisplatin?

Is there anyone with the experience to answer these questions?

Go IPIX
=======================================
Posted On: 11/17/2018 10:21:24 PM
Posted By: Squar
Re: TheDane #51237
The 40 million plus shares pushed onto the market from Aspire.
The relentless smear campaign.
No money for B-ABSSSI phase 3.
Prurisol phase 2 (it was not a phase 2a at the time) results not good enough for phase 3.
Prurisol 2b interim canceled, results delayed indefinitely by lack of payment to CRO.

These all provided ample suppressive fire for the shorts to continue working the stock.

Also, and I know it's hard for some here to believe, there are actually people out there who do not believe IPIX will make a deal. If you're one of those people, shorting here makes total sense.

It's short/cover, short/cover, short/cover. Your numbers come out much bigger than with a single trade where 100% is the max you can earn.

Short at $4.00
Cover at $1.00 to make at 75% return.
Short at $1.00 with all those profits and releverage
Cover at $0.25 to make another 75% return.
Short at $0.25 with all those profits and releverage
Cover at $0.125 to make another 50% return.

That's a 350% ($1000 in, $4500 out) return to here.

Not much meat left on the bone right? Wrong.

Short at $0.125 with all those profits and releverage
Cover at $0.0625 to make another 50% return

That's at 580% return over all.

Shorting is great money if IPIX doesn't catch you off guard with a buyout. That won't happen if you short against your long position as a hedge. Short, turn a profit, split the profit between more shorting and averaging down the long position. Ring that goose's neck til she drops the gold eggs.


Read More: https://investorshangout.com/post/view?id=526...z5XiA2et1j

________________________________________

Posted On: 03/24/2018 5:01:06 PM

Posted By: Phteven C

Re: Drano #43643

I think most of these shorts sellers are actually net longs working the trades. Take this sample IPIX portfolio:

100K core long position
30K long trade position
30K short position

I suspect they are long term bulls so they are comfortable being long 100K-130K at any time but they will take a 30K short position when they think a temporary peak has been hit and then cover when it dips down. This means they can make money trading the volatility, lowering their cost basis, and still be guarenteed a 100K long position in the even of a big announcement. The short position is not ever at risk because the 30K long trading position cancels it out.

On a stock like IPIX, which has declined steadily the past three years, it would have been a very wise strategy to use. Since the short interest is miniscule (less than 1% of the OS), the borrowing costs would be quiet small as well.

This of course neglects any sort of naked short position hiding under the water but the premise holds the same regardless. Only an idiot shorts something like this without a hedge.

Wish I was smart enough to do this.

Go IPIX!
==============================
See any writing style similarities on the above????????


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading

Top 5 Most Recently Viewed Articles

Homestyle Direct Expands Healthy Meal Delivery in Pennsylvania

Updated Category News Views 278

Homestyle Direct's Nutritional Meal Initiative Homestyle Direct is revolutionizing how eligible Medicaid members enjoy nutritious meal options. The company, based in Twin Falls, Idaho, has gained significant traction among Pennsylvania residents, particularly in areas like Erie and Allegheny counties. This initiative aligns perfectly with their commitment to providing...

Continue Reading
Elis Reports Key Shareholder Information and Voting Rights

Updated Category News Views 174

Understanding Share Capital and Voting Rights at Elis The clarity of capital structure and voting rights is crucial for investors. In the context of Elis, a prominent player in its field, this information allows stakeholders to make informed decisions regarding their investments. What is Share Capital? Share capital refers to the funds raised by a company in exchange for...

Continue Reading
Huntington Bancshares Announces Dividends for Common and Preferred Stocks

Updated Category News Views 211

Huntington Bancshares Declares Dividends for Shareholders Huntington Bancshares Incorporated has officially announced a noteworthy decision by its Board of Directors. In a recent update, the bank declared a quarterly cash dividend on its common stock, designated as Nasdaq: HBAN, maintaining its dividend at $0.155 per common share, which remains consistent with its...

Continue Reading
Grand Bay Hotel Joins Marriott Family for Enhanced Guest Experience

Updated Category News Views 385

Grand Bay Hotel Embraces Marriott Affiliation The Grand Bay Hotel San Francisco has embarked on an exciting new journey as it officially becomes part of the Marriott hotel portfolio, opening the door to a wealth of global opportunities and unique benefits for its guests. This strategic affiliation promises to enhance the overall guest experience, from the luxurious...

Continue Reading
Strategic Alliance to Transform China's Auto Parts Sector

Updated Category News Views 194

Autozi Internet Technology's New Partnership Autozi Internet Technology (Global) Ltd. (NASDAQ: AZI) is making waves in the auto parts industry with its latest strategic partnership. This collaboration with the China Auto Maintenance Parts Alliance signifies a major move towards digitizing the auto parts market. On a recent day, Autozi's stock experienced an impressive...

Continue Reading